<DOC>
	<DOCNO>NCT01140048</DOCNO>
	<brief_summary>This prospective , multicenter , observational study participant complete 24-week , placebo-controlled MK-0476 Protocol 272 ( NCT00076973 ) study montelukast treatment respiratory symptom subsequent RSV-induced bronchiolitis . The purpose study well understand clinical demographic correlate asthma atopic disorder child ( age 6 year ) history severe RSV-induced bronchiolitis .</brief_summary>
	<brief_title>Respiratory Syncytial Virus ( RSV ) Follow-Up Study ( MK-0476-374 )</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<criteria>successfully complete MK0476 Protocol 272 RSVinduced bronchiolitis entry Protocol 272 develop diagnose illness congenital disorder could immediately life threaten</criteria>
	<gender>All</gender>
	<minimum_age>18 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Asthma</keyword>
</DOC>